Aubagio is a specialty medication for the treatment of Multiple Sclerosis (MS). MS is a chronic, debilitating condition that affects the nervous system. It can cause symptoms throughout the entire body. When someone has MS, their immune system attacks their nervous system and causes permanent damage. It is not known exactly what causes MS. However, there are likely various factors, including genetic and environmental causes. Aubagio works by decreasing the activity of the immune system, and protecting the nerve cells. Fact Table Formula C12H9F3N2O2 License US FDA, EU EMA Bioavailability 100% Legal status Rx-only Chemical Name Teriflunomide Elimination half-life 2 weeks Dosage (Strength) 7mg, 14mg Pregnancy Consult Doctor Brands Aubagio Protein binding More than 99.3% PubChem CID 54684141 MedlinePlus a613010 ChEBI 68540 ATC code L04AA31 DrugBank DB08880 KEGG D10172 Routes of administration By mouth

Aubagio (Teriflunomide)

The dosage of Aubagio is 7-14 mg by mouth once daily with or without food. Take this medication exactly as prescribed by your doctor.
Tell your doctor if you have any of the following adverse reactions while taking this drug: Acute hepatic failure, Alopecia, Anaphylaxis, Angioedema, Arthralgia, Colitis, Cytomegalovirus disease, Diarrhea, Drug reactions with eosinophilia and systemic symptoms, Exacerbation of psoriasis, Headache, Hepatic injury, Hypersensitivity reaction, Hypertension, Hypophosphatemia, Increased serum alanine aminotransferase, Interstitial pulmonary disease, Jaundice, Lymphocytopenia, Nail disease, Nausea, Neutropenia, Pancreatitis, Paresthesia, peripheral neuropathy, Psoriasis, Pustular psoriasis, Stevens-Johnson syndrome, Thrombocytopenia, Toxic epidermal necrolysis, Tuberculosis

Aubagio (Teriflunomide)

Directions

Ingredients

Cautions

Side Effects